This page was last edited on April 21, 2022 at 9:20 am
For the incidence of cigarette smoking and other forms of toxic tobacco use to decrease, current users must quit or switch to reduced risk products (RRPs), and non-smokers and those who do not use tobacco in any form must not start. The material net gain for public health can only be achieved if substantially more smokers quit than non-smokers start. The Foundation for a Smoke-Free World considers the research being conducted globally, as well as gaps in current knowledge, to assess the priorities for the Foundation’s research in this area.
The Foundation focuses on non-duplicative and novel research associated with smoking cessation and tobacco harm reduction (THR), including:
correcting misinformation and disinformation about THR, so that it is assessed based on evidence;
supporting medical and other health professionals in advising smokers and tobacco users, with an emphasis on marginalized and diverse communities, and LMICs.
The Rose Research Center is conducting research that evaluates smoking cessation and harm reduction strategies to help smokers quit or switch to reduced risk products. The Center is also examining the acceptability and outcome of a harm reduction approach to tobacco use for individuals with serious behavioral health disorders and determine the association with decrease in smoking.
The CoEHAR’s research program encompasses developed and developing countries and uses a multidisciplinary approach to better understand harm reduction. Its projects include, for example, the chemical characterization of nicotine products and multiyear cohort studies